Enliven Therapeutics Inc. (ELVN)

ELVN trades at $20.24, 15.7% above the near-term max pain of $17.5 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$95), signaling increased put positioning or downside protection. Key magnetic zone at 18 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ELVN shows a downward trend from 95 to 2.5, indicating bearish sentiment or hedging activity. The 325% spread signals divergent expectations across timeframes. Most levels below 20.24 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.